Status:
COMPLETED
i2TransHealth: Interdisciplinary, Internet-based Trans Health Care
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Gender Dysphoria
Gender Identity Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
i2TransHealth is a randomized controlled trial that investigates the outcomes of an internet-based health care approach for transgender and gender diverse (TGD) people. As a health services research p...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Gender different from their assigned sex at birth
- resident at least 50 km outside Hamburg
- present themselves with treatment needs (TS/GD) to one of the participating physicians in the i2TransHealth network, or direct contact with institute and/or e-health platform
- receive the suspected diagnosis TS/GD during an initial interview in the UKE
- can operate the video chat cognitively, verbally and auditory
- Able to read, speak, and understand German
- Written informed consent after written and oral information
Exclusion
- Under 18 years of age
- Missing informed consent
- Unable to speak German
- Indication for inpatient treatment, e.g. due to acute psychotic symptoms (self-report, Prodromal Questionnaire, PQ-B) or severe depressive symptoms (self-report, BDI-II ≥ 29)
- Acute suicidal tendencies
- Decrease in intelligence (IQ below 70)
- Acute drug intoxication
- Failure to meet technical requirements (no Internet access, lack of IT knowledge)
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT04290286
Start Date
May 1 2020
End Date
September 30 2022
Last Update
November 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246